Squar Milner Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,043
Closed -$718K 13
2020
Q2
$718K Sell
3,043
-62
-2% -$14.1K 0.41% 64
2020
Q1
$629K Buy
3,105
+190
+7% +$41.5K 0.38% 52
2019
Q4
$702K Sell
2,915
-223
-7% -$49.2K 0.35% 57
2019
Q3
$798K Buy
3,138
+681
+28% +$131K 0.41% 64
2019
Q2
$453K Sell
2,457
-206
-8% -$36.9K 0.31% 76
2019
Q1
$505K Hold
2,663
0.37% 55
2018
Q4
$518K Buy
2,663
+28
+1% +$5.46K 0.5% 41
2018
Q3
$546K Sell
2,635
-313
-11% -$61.7K 0.49% 43
2018
Q2
$544K Hold
2,948
0.48% 48
2018
Q1
$503K Hold
2,948
0.64% 45
2017
Q4
$584K Buy
+2,948
New +$522K 0.71% 36

Other funds holding AMGN

Squar Milner Financial Services's AMGN Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Amgen (AMGN) in Q3 2020, closing a stake of 3,043 shares — an estimated $718K sold.

Squar Milner Financial Services first reported a position in AMGN in Q4 2017 and held it in 11 quarters. The position peaked at $798K in Q3 2019. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 3,043 Amgen shares in Q3 2020, an estimated $718K.
  • Squar Milner Financial Services first reported a position in Amgen in Q4 2017 and held it in 11 quarters.
  • Squar Milner Financial Services's Amgen position peaked at $798K in Q3 2019.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.